1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. MIDDLE EAST AND AFRICAN CONTINUOUS GLUCOSE MONITORING (CGM) MARKET, BY APPLICATION
5.1. Introduction
5.2. Diabetes Patients
5.3. Critical Patients
6. MIDDLE EAST AND AFRICA CONTINUOUS GLUCOSE MONITORING (CGM) MARKET, BY END-USER INDUSTRY
6.1. Introduction
6.2. Hospitals
6.3. Diagnostic Centers & Clinics
6.4. Home Care
7. MIDDLE EAST AND AFRICA CONTINUOUS GLUCOSE MONITORING (CGM) MARKET, BY COUNTRY
7.1. Introduction
7.2. UAE
7.3. Israel
7.4. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
9. COMPANY PROFILES
9.1. Abbott Laboratories
9.2. Dexcom, Inc.
9.3. Medtronic plc
9.4. Senseonics Holdings, Inc.
9.5. Insulet Corporation
9.6. Roche Holding AG
9.7. Ypsomed AG
9.8. GlySens Incorporated
9.9. Tandem Diabetes Care, Inc.
9.10. Nemaura Medical Inc.